Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
5.96
-0.83 (-12.22%)
May 14, 2025, 12:33 PM AEST

Revenue by Product

Fiscal year is July - June.
Year Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Dermatology
174.86M
Log In
Log In
Log In
Log In
Dermatology Growth
206.81%
Log In
Log In
Log In
Log In
Womens Health
142.83M
Log In
Log In
Log In
Log In
Womens Health Growth
130.78%
Log In
Log In
Log In
Log In
International
70.71M
Log In
Log In
Log In
Log In
International Growth
9.29%
Log In
Log In
Log In
Log In
Metrics Contract Services
-
Log In
Log In
Log In
Log In
Metrics Contract Services Growth
-
Log In
Log In
Log In
Log In
Generic Products
-
Log In
Log In
Log In
Log In
Generic Products Growth
-
Log In
Log In
Log In
Log In
Specialty Products
-
Log In
Log In
Log In
Log In
Specialty Products Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is July - June.
Year Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
United States
322.13M
Log In
Log In
Log In
Log In
United States Growth
158.81%
Log In
Log In
Log In
Log In
Australia and New Zealand
40.34M
Log In
Log In
Log In
Log In
Australia and New Zealand Growth
-2.09%
Log In
Log In
Log In
Log In
Canada
13.37M
Log In
Log In
Log In
Log In
Canada Growth
34.62%
Log In
Log In
Log In
Log In
Europe and Other
7.13M
Log In
Log In
Log In
Log In
Europe and Other Growth
98.00%
Log In
Log In
Log In
Log In
Asia
5.44M
Log In
Log In
Log In
Log In
Asia Growth
23.78%
Log In
Log In
Log In
Log In
Australia
-
Log In
Log In
Log In
Log In
Australia Growth
-
Log In
Log In
Log In
Log In
Other
-
Log In
Log In
Log In
Log In
Other Growth
-
Log In
Log In
Log In
Log In